Safety, Pharmacokinetics, and Pharmacodynamics in Healthy Volunteers Treated With GDC‐0853, a Selective Reversible Bruton's Tyrosine Kinase Inhibitor by Herman, Ann E., Chinn, Leslie W., Kotwal, Shweta G., Murray, Elaine R., Zhao, Rui, Florero, Marilyn, Lin, Alyse, Moein, Anita, Wang, Rena, Bremer, Meire, Kokubu, Serika, Serone, Adrian P., Hanze, Eva L., Viberg, Anders, Morimoto, Alyssa M., Winter, Helen R., Katsumoto, Tamiko R.

Get full text